...
首页> 外文期刊>Techniques in vascular and interventional radiology >The United States registry for fibromuscular dysplasia: New findings and breaking myths
【24h】

The United States registry for fibromuscular dysplasia: New findings and breaking myths

机译:美国纤维肌发育不良登记处:新发现和打破神话

获取原文
获取原文并翻译 | 示例

摘要

Fibromuscular dysplasia (FMD) is a nonatherosclerotic, noninflammatory arterial disease predominantly seen in women. Most FMD cases are classified as medial fibroplasia, which has the appearance of a string of beads on angiography. Until recently, FMD was thought to be seen in women in their 20s and 30s, with more than 60%-75% of cases occurring in the renal artery and 25% of cases in the carotid artery. Hypertension was regarded as the primary symptom seen in these patients followed by a small number of patients presenting with intracranial aneurysms with subarachnoid hemorrhage. The United States Registry of FMD, a patient registry, has broken many preconceived notions as well as provided more in-depth knowledge of this uncommon disorder. In this review, we discuss the findings of this registry and its use in understanding this disorder. In addition to the registry, we review other recent studies and future directions in the diagnosis and management of this disorder.
机译:纤维肌发育不良(FMD)是一种非动脉粥样硬化,非炎症性动脉疾病,主要见于女性。大多数FMD病例被分类为内侧纤维化,在血管造影术上出现一串珠子。直到最近,人们还认为FMD在20多岁和30多岁的女性中可见,其中超过60%-75%的病例发生在肾动脉,而25%的病例发生在颈动脉。高血压被认为是这些患者的主要症状,其次是少数伴有蛛网膜下腔出血的颅内动脉瘤患者。美国FMD注册机构(患者注册机构)打破了许多先入为主的观念,并提供了对这种罕见疾病的更深入的了解。在这篇综述中,我们讨论了该注册表的发现及其在理解这种疾病中的用途。除注册表外,我们还将复查该疾病的诊断和管理方面的其他最新研究和未来方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号